Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Venlafaxine Extended-Release Tablets and Pregabalin Extended-Release Tablets.
USFDA has approved Venlafaxine Extended-Release Tablets, USP 37.5 mg, 75 mg, 150 mg and 225 mg Extended-Release (ER) Tablets and Pregabalin ER Tablets, USP 82.5 mg, 165 mg and 330 mg which is generic of Lyrica CR.
- Read more about Zydus receives USFDA approval for Venlafaxine and Pregabalin ER Tablets
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/zydus-receives-usfda-approval-for-venlafaxine-and-pregabalin-extended-release-tablets
No comments:
Post a Comment